Featured Abstracts
Review key findings and research highlights presented at major industry conferences and events.
Featured Content
Cureus competition winner
A Primary Liver Cancer Patient Treated With Stereotactic Body Radiation Therapy Using Diaphragm Motion Surrogate Tracking in CyberKnife
cureus competition winner
Commissioning Tests of Radixact Synchrony Using Patient-Specific 3D-Printed Lung Phantom Inserts
cureus competition winner
A Case of a 12-cm Huge Hepatocellular Carcinoma Treated Successfully With Two-Stage CyberKnife Stereotactic Body Radiation Therapy
Featured Case Studies
Precision and Innovation: Insights on a robust radiation oncology practice from a long-term CyberKnife® System user
According to the World Health Organization, in 2050 more than 35 million new cancer cases will be diagnosed, a 77 percent increase from the estimated 20 million cases in 20221. Men are anticipated to be the hardest hit, with a study in the journal Cancer finding that global cancer cases
Deep Inspiration Breath Hold Using VitalHold™ on the Radixact® System
A 45-year-old female patient was diagnosed with pT2N1M0 invasive ductal carcinoma of the left breast. The patient underwent breast conservation surgery with axillary dissection, followed by chemotherapy and radiation therapy. Radiation therapy was delivered by the Radixact® System, the latest generation of the TomoTherapy® Platform with surface guided radiotherapy (SGRT)
Las Vegas CyberKnife® Experience with CyberKnife VOLO™ Optimization: Increase in Patient Throughput & Daily Volumes
Las Vegas CyberKnife worked with Accuray to upgrade their CyberKnife G4 version 9.6 and MultiPlan® version 4.5 to decrease treatment planning times significantly with new planning hardware and optimized software in the first release of Accuray Precision 1.0 and treatment delivery version 11.0.
2849: Bladder Preservation Using Immunotherapy and Radiotherapy in Muscle-Invasive Bladder Cancer
Isabela Gaztelu et al. | ESTRO | 2025
3607: Stereotactic Body Radiotherapy (SBRT) for Non Surgical Cholangiocarcinoma
Jesús Romero Fernandez et al. | ESTRO | 2025
3640: TomoTherapy for In-transit or Metastatic Lower Limb Melanoma
Joaquín Velasco-Jiménez et al. | ESTRO | 2025
3062: Definitive TomoTherapy-based Radiotherapy Facial Lentigo Maligna. The Experience of Centro di Riferimento Oncologico di Aviano CRO-IRCCS
Giuseppe Fanetti et al. | ESTRO | 2025
899: Prognostic Factors in Extremity Soft Tissue Sarcomas Treated with Radiotherapy
Arthur Lebas et al. | ESTRO | 2025
447: IMRT by TomoTherapy with Concurrent Weekly Cisplatin Followed by Brachytherapy HDR in Locally Advance Cervical Cancer (Prospective Study)
Sofiane Mellouk et al. | ESTRO | 2025
67: Comparative Analysis of 3DCRT, IMRT and Helical TomoTherapy in Glioblastoma: Evaluation of Recurrence Dynamics
Sweekruti Hegde et al. | ESTRO | 2025
3750: Long-term Follow-up Results of Helical TomoTherapy for Non-metastatic Breast Cancer: Single Center Experience
Abdelkarim Uakkas et al. | ESTRO | 2025
3898: One-day Urethral-sparing, HDR-like, Prostate Cancer Robotic SBRT: Preliminary Results of the PRO-FAST Trial
Andrei Fodor et al. | ESTRO | 2025
4009: Film Dosimetry for Surface Irradiation Without Physical Bolus, Calculated in RayStation for Radixact X9
Edwin Rozo et al. | ESTRO | 2025
3802: Clinical Evaluation of Quality Assurance Method Using 4D Moving Phantom for Synchrony’s Lung Tumor Tracking
Koji Sasaki et al. | ESTRO | 2025
4034: Initial Experience and Short-Term Clinical Outcomes of Lung cancer Patients Treated with SBRT Using the Radixact Synchrony Tumor Tracking System
Kadriye Tezcanli et al. | ESTRO | 2025
3734: Analysis and Comparison of CyberKnife MLC Collimator Versus IRIS Collimator in Prostate SBRT
Gaetano Gagliardo et al. | ESTRO | 2025
